The Pharmaceutical Logistics Market report segments the industry into By Product (Generic Drugs, Branded Drugs), By Mode of Operation (Cold Chain Transport, Non-Cold Chain Transport), By Application (Biopharma, Chemical Pharma, Specialized Pharma), By Mode of Transport (Air Shipping, Rail Shipping, Road Shipping, Sea Shipping), and Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World).

Global Pharmaceutical Logistics Market to grow from US$ 95.47 Billion in 2023 to US$ 239.33 Billion by 2032, CAGR 9.8%.

In 2020, the global pharmaceutical logistics market was worth over **** billion euros. By 2025, influenced by further responses to the coronavirus pandemic, the return to medical services, the aging population, and the rise of non-contagious diseases, the pharmaceutical logistics market will increase to over ** billion euros in size.

The global pharmaceutical logistics market size reached USD 91.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 154.0 Billion by 2033, exhibiting a growth rate (CAGR) of 5.96% during 2025-2033. The rising need for efficient and reliable logistics networks, the development of medical facilities across rural and geographically extended locations, and significant growth in the pharmaceutical industry represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical logistics market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on type, component and application.

The Europe Pharmaceutical Logistics Market report segments the industry into By Product (Generic Drugs, Branded Drugs), By Operation (Cold Chain Transport, Non-cold Chain Transport), By Application (Biopharma, Chemical Pharma), By Transportation (Airways, Railways, Roadways, Seaways), and By Geography (Germany, United Kingdom, The Netherlands, France, Italy, Spain, Poland, Belgium, Sweden, Rest of Europe).

Snapshot img

Pharmaceutical Logistics Market Size 2024-2028

The pharmaceutical logistics market size is forecast to increase by USD 11.96 billion at a CAGR of 2.46% between 2023 and 2028. The market is experiencing significant growth due to the increasing global pharmaceutical sales and the high demand for personalized medicine. Wholesalers, clinics, and hospitals are key consumers in this market, necessitating the need for efficient and reliable logistics solutions. However, challenges such as instability in supply chains and the risk of contamination during transportation pose significant threats. To mitigate these risks, advanced technologies like GPS tracking and adherence to Good Distribution Practices (GDP) guidelines are being adopted.

Furthermore, sterilization techniques are being employed to ensure the safety and efficacy of pharmaceutical products during transit. Despite these advancements, the high cost associated with pharmaceutical logistics remains a significant barrier to market growth.

Request Free Sample

The market is experiencing significant growth due to the increasing demand for biological pharmaceuticals and temperature-sensitive medications. Cold chain logistics plays a crucial role in ensuring the safe and efficient transportation and storage of these products. The storage segment accounts for a major share of the market, with the need for specialized facilities to maintain the required temperature conditions for biological pharmaceuticals. The transportation segment, including air freight logistics and sea freight logistics, is also witnessing growth due to the global nature of the pharmaceutical industry and the need for emergency use authorizations for the rapid delivery of critical medications.

Further, agility and Delivery Limited are some of the key players focusing on providing agile and efficient logistics solutions for pharmaceutical products. The expansion of e-commerce and the growing popularity of over-the-counter medications are also driving the market. Temperature-sensitive drugs, such as Covishield and Covaxin, require specialized logistics solutions, including telematics and cloud-based systems, to ensure their integrity during transportation and storage. Non-cold chain logistics also play a role in the market, particularly for less sensitive pharmaceutical products.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Non-cold chain logistics
  Cold chain logistics


Service

  Storage
  Transportation


Geography

  APAC

    China
    India


  North America

    US


  Europe

    Germany
    UK


  Middle East and Africa



  South America

By Type Insights

The non-cold chain logistics segment is estimated to witness significant growth during the forecast period. Pharmaceutical logistics encompasses the transportation and distribution of various pharmaceutical products, including those that do not require strict temperature control, referred to as non-cold chain logistics. These products, such as over-the-counter drugs, vitamins, and supplements, can be transported using standard logistics methods, including air freight, sea freight, and overland transportation. The pharmaceutical industry relies on various packaging materials like blister packs, bottles, labels, and inserts for these products, which are generally not sensitive to temperature.

Further, non-cold chain logistics play a significant role in the efficient distribution of a broad spectrum of pharmaceutical products, including oral medications, topical creams, medical devices, and non-perishable medical supplies. With the expansion of e-commerce and the increasing demand for quick delivery, agility in pharmaceutical logistics has become crucial. The Emergency Use Authorization (EUA) and Biologics License Application (BLA) processes require timely and efficient logistics to ensure the delivery of essential medicines and treatments.

Get a glance at the market share of various segments Request Free Sample

The Non-cold chain logistics segment accounted for USD 65.10 billion in 2018 and showed a gradual increase during the forecast period.

Regional Insights

APAC is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The market in the Asia Pacific (APAC) region is witnessing significant growth due to the increasing population and resulting demand for healthcare services. With countries such as China and India experiencing strong economic expansion, healthcare spe

The United Kingdom Pharmaceutical Logistics Market Report is Segmented by Product (Generic Drugs, Branded Drugs), by Mode of Operation (Cold Chain Transport, Non-Cold Chain Transport), by Application (Bio Pharma, Chemical Pharma), by Mode of Transport (Air, Rail, Road, and Sea) the Report Offers Market Size and Forecast for United Kingdom Pharmaceutical Logistics Market in Value (USD) for all the Above Segments.

Global Pharmaceutical Logistics market size is expected to reach $216.57 billion by 2029 at 11.7%, segmented as by type, cold chain logistics, non-cold chain logistics

Global Pharmaceutical Logistics Market was valued at USD 93.23 Billion in 2023 and is expected to reach USD 140.83 Billion by 2029 with a CAGR of 7.09% during the forecast period.

In 2020, North America was the biggest pharmaceutical logistics market, worth over **** billion euros. In that year, the global pharmaceutical logistics market was sized at over **** billion euros.

The US Pharmaceutical Logistics Market report segments the industry into By Product (Generic Drugs, Branded Drugs), By Mode of Operation (Cold Chain Transport, Non-cold Chain Transport), By Services (Transport, Warehousing Services, Value-added Services and Other Services). Get five years of historical data alongside five-year market forecasts.

Global Pharmaceutical Logistics Market size is estimated to be US$ 99.89 Bn in 2025 and is expected to expand at a CAGR of 9.3%, reaching US$ 186.14 Bn by 2032.

Snapshot img

The pharmaceutical logistics market in North America has the potential to grow by USD 3.56 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 4.15%.

This pharmaceutical logistics market in North America research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by application (non-cold chain and cold chain) and geography (the US, Canada, and Mexico). The pharmaceutical logistics market in North America report also offers information on several market vendors, including Agility Public Warehousing Company KSCP, Air Canada, C.H. Robinson Worldwide Inc., Deutsche Post DHL Group, Expeditors International of Washington Inc., FedEx Corp., Kuehne + Nagel International AG, Penske Truck Leasing Co. LP, Ryder System Inc., and United Parcel Service Inc. among others.

What will the Pharmaceutical Logistics Market Size in North America be in 2021?

Browse TOC and LoE with selected illustrations and example pages of Pharmaceutical Logistics Market in North America

Get Your FREE Sample Now!

Pharmaceutical Logistics Market in North America: Key Drivers and Trends

Based on our research output, there has been a negative impact on the market growth during and post COVID-19 era. The rise in pharmaceutical sales is notably driving the pharmaceutical logistics market growth in North America, although factors such as operational issues may impede market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the pharmaceutical logistics market in North America get your FREE report sample now.

This pharmaceutical logistics market in North America analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.

Who are the Major Pharmaceutical Logistics Market Vendors in North America?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

Agility Public Warehousing Company KSCP
Air Canada
C.H. Robinson Worldwide Inc.
Deutsche Post DHL Group
Expeditors International of Washington Inc.
FedEx Corp.
Kuehne + Nagel International AG
Penske Truck Leasing Co. LP
Ryder System Inc.
United Parcel Service Inc.

The pharmaceutical logistics market in North America is fragmented and the vendors are deploying growth strategies such as investing in cloud-based supply chain solutions to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the pharmaceutical logistics market in North America forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for Pharmaceutical Logistics Market in North America?

For more insights on the market share of various regions Request for a FREE sample now!

77% of the market’s growth will originate from the US during the forecast period. Market growth in this region will be slower than the growth of the market in Canada.

The continued growth of specialty pharmaceuticals will facilitate the pharmaceutical logistics market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Application Segments in the Pharmaceutical Logistics Market in North America?

To gain further insights on the market contribution of various segments Request for a FREE sample

Healthcare products that require refrigeration, such as insulin and vaccines are transported and stored under the cold chain network. Products that are more temperature-sensitive are more complex to handle. Many top-selling pharmaceutical products require cold chain logistics. The increase in the number of refrigerated pharmaceutical products will provide a boost to the market for cold chain pharmaceutical logistics.

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the pharmaceutical logistics market size in North America.

Request for a FREE sample

What are the Key Factors Covered in this Pharmaceutical Logistics Market in North America Report?

CAGR of the market

The pharmaceutical logistics market, valued at $531.42 million in 2025, is projected to experience robust growth, driven by several key factors. The increasing demand for temperature-sensitive pharmaceutical products, particularly biologics and specialized medications, necessitates sophisticated cold chain infrastructure and reliable transportation networks. This demand is further fueled by the expanding global pharmaceutical industry and the growing prevalence of chronic diseases requiring continuous medication. Technological advancements, such as real-time tracking and monitoring systems, are enhancing supply chain efficiency and improving product safety. Furthermore, stringent regulatory requirements regarding drug handling and distribution are creating opportunities for specialized logistics providers offering compliant services. However, the market faces challenges including high infrastructure costs associated with maintaining cold chain facilities and the complexities of navigating diverse global regulations. The increasing need for end-to-end visibility and traceability across the supply chain is driving the adoption of advanced technologies and integrated logistics solutions. Market segmentation reveals significant opportunities within different product types (generic vs. branded drugs), modes of operation (cold chain vs. non-cold chain), applications (biopharma, chemical pharma, specialized pharma), and modes of transport (air, rail, road, sea). While North America and Europe currently dominate market share, the Asia-Pacific region is expected to witness substantial growth, fueled by increasing healthcare spending and expanding pharmaceutical manufacturing capabilities in countries like India and China. Major players, including Kloosterboer, World Courier, and others, are leveraging their expertise and infrastructure to capitalize on market expansion and offer comprehensive solutions to pharmaceutical companies. The competitive landscape is characterized by both large multinational corporations and specialized niche players, highlighting the diverse needs of the pharmaceutical supply chain. The projected CAGR of 5.53% from 2025-2033 indicates a promising outlook for sustained market expansion. This comprehensive report provides an in-depth analysis of the global pharmaceutical logistics market, offering valuable insights for stakeholders across the pharmaceutical supply chain. The study covers the period 2019-2033, with 2025 as the base year and a forecast period extending to 2033. The market's size is valued in millions of units, providing a clear picture of its growth trajectory and future potential. This report is essential for businesses seeking to understand the complexities of pharmaceutical logistics, including cold chain management, regulatory compliance, and emerging technological advancements. Key search terms include: pharmaceutical logistics, cold chain logistics, pharmaceutical transportation, biopharmaceutical logistics, drug supply chain, temperature-sensitive logistics. Recent developments include: August 2023: UPS Healthcare (a global logistics service provider) expanded its UPS Premier service to India, marking another step in ongoing service and technology upgrades to meet the growing needs of critical time and temperature-sensitive healthcare shipments. This expansion allows Indian customers to access UPS Premier Gold service benefits, including "first-in, first-off" prioritization, built-in service recovery features within the UPS global network, and 24/7 control tower monitoring., May 2023: DHL (a global logistics company) opened its newest Indianapolis facility. The facility is spread across more than 30,000 square-foot new end-of-runway centers at the Indianapolis International Airport. Under this end-to-end expansion process, the company ships pharmaceuticals and other life-sciences products without the need for specialized temperature-controlled unit loading devices, maintaining quality control.. Key drivers for this market are: 3., Online Pharmacies to Facilitate Growth3.; Increasing Demand for Over-the-counter (OTC) Medicines. Potential restraints include: 3., High Cost of Logistics3.; Stringent Government Regulations. Notable trends are: Increasing Demand for Cold Chain Logistics in the Sector.

The global pharmaceutical logistics market size was valued at USD 300.78 Billion in 2024, driven by the increasing dependency on cutting-edge technologies to optimize the delivery process across the globe. The market size is anticipated to grow at a CAGR of 8.40% during the forecast period of 2025-2034 to achieve a value of USD 673.82 Billion by 2034.

As per Cognitive Market Research's latest published report, the Global Pharmaceutical Logistics market size was $81.23 Billion in 2022 and it is forecasted to reach $142.41 Billion by 2030. Pharmaceutical Logistics Industry's Compound Annual Growth Rate will be 7.3% from 2023 to 2030. What is Driving Pharmaceutical Logistics Market?

The primary drivers for the pharmaceutical logistics market are the rising demand for over-the-counter (OTC) medications and the growing significance of fast-track assistance in the healthcare industry. The rise in popularity of over-the-counter (OTC) medicines such as vitamins, minerals, and supplements (VMS), remedies for the common cold and cough, gastrointestinal drugs, and dermatology products is also related to the market's expansion.

What are the opportunities and restraints for the Pharmaceutical logistics market?

Throughout the projected period, the market is anticipated to benefit from the rising need for hospitals and medical facilities as well as the rising demand for pharmaceutical logistics by air and sea. Yet, operational challenges in cold chain logistics that raise expenses of operation can limit market expansion. What is Pharmaceutical Logistics?

The movement of pharmaceutical items from the manufacturer to the end-user, who may be a patient, a pharmacy, or a healthcare facility, is referred to as pharmaceutical logistics. The management of the supply chain, which includes the purchase, storage, transportation, and distribution of pharmaceutical items, is referred to as pharmaceutical logistics. It is a crucial component of the pharmaceutical industry since proper drug delivery is necessary for patient safety and quality healthcare. Assuring that products are delivered in accordance with numerous laws and quality requirements is another aspect of pharmaceutical logistics. This entails preserving the quality of the goods throughout shipping and storage, as well as tracking the movement of medicines along the supply chain to thwart fraud and diversion.

Pharmaceutical Logistics Market size was USD 86 Billion in 2022 and is expected to reach USD 202.78 Billion in 2034, and register a revenue CAGR of 10% during the forecast period.

Pharmaceutical Logistics Market Outlook

According to our latest research, the global pharmaceutical logistics market size reached USD 95.2 billion in 2024, reflecting robust expansion driven by the increasing demand for efficient and secure transportation of pharmaceutical products worldwide. The market is expected to grow at a CAGR of 8.1% from 2025 to 2033, reaching a projected value of USD 187.6 billion by 2033. This impressive growth trajectory is fueled by the rising prevalence of chronic diseases, the expansion of the pharmaceutical industry, and the growing need for temperature-sensitive logistics solutions to ensure drug efficacy and safety throughout the supply chain. As per our latest research, the pharmaceutical logistics market continues to evolve rapidly, underpinned by technological advancements and the globalization of pharmaceutical manufacturing and distribution.

One of the primary growth factors propelling the pharmaceutical logistics market is the surge in demand for temperature-controlled logistics, commonly known as cold chain logistics. The increasing production and distribution of biologics, vaccines, and specialty drugs, many of which require stringent temperature control, have created a pressing need for advanced logistics solutions. Pharmaceutical companies are investing heavily in state-of-the-art cold storage facilities, GPS-enabled monitoring systems, and real-time tracking technologies to maintain product integrity and comply with regulatory standards. These innovations not only reduce the risk of spoilage and wastage but also enhance the overall efficiency and reliability of the pharmaceutical supply chain, thereby driving market growth.

Another significant driver is the globalization of the pharmaceutical industry, which has led to the expansion of cross-border trade and the need for sophisticated logistics networks. As pharmaceutical manufacturing hubs shift towards emerging economies in Asia Pacific and Latin America, there is a growing requirement for integrated logistics services that can manage complex international supply chains. This includes compliance with diverse regulatory frameworks, customs clearance, and last-mile delivery solutions. The increasing adoption of digital technologies such as blockchain, IoT, and artificial intelligence in logistics operations is further optimizing inventory management, reducing lead times, and enhancing visibility across the supply chain, contributing to the sustained growth of the pharmaceutical logistics market.

The rise of e-commerce and direct-to-patient delivery models has also played a pivotal role in shaping the pharmaceutical logistics landscape. With patients and healthcare providers demanding faster and more reliable delivery of medicines, logistics providers are innovating their service offerings to include value-added services such as real-time order tracking, temperature assurance, and customized packaging. Furthermore, the COVID-19 pandemic has underscored the critical importance of resilient and agile logistics networks, prompting pharmaceutical companies to diversify their supply chains and invest in risk mitigation strategies. These factors collectively underscore the dynamic nature of the pharmaceutical logistics market and its capacity for sustained expansion in the foreseeable future.

From a regional perspective, North America continues to dominate the pharmaceutical logistics market, accounting for the largest share in 2024 due to its advanced healthcare infrastructure, high pharmaceutical consumption, and strong presence of leading logistics providers. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing pharmaceutical manufacturing activities, rising healthcare expenditures, and expanding middle-class populations. Europe also holds a significant market share, supported by stringent regulatory requirements and a well-established pharmaceutical industry. Latin America and the Middle East & Africa are emerging as attractive markets, fueled by improving healthcare access and rising investments in pharmaceutical distribution networks. These regional trends highlight the global nature of the pharmaceutical logistics market and the diverse opportunities for growth across different geographies.

Service Type Analysis

The pharmaceutical logistics market is segmented by service type into transportation, warehousing, and value-added services. Transportation remains

Global Bio Pharma Logistics Market is anticipated to grow at a CAGR of 7.20% during the forecast period, with an estimated size and share exceeding USD 192.52 billion by 2032, according to projections.

Snapshot img

Cold Chain Logistics Market For Pharmaceuticals Industry Size 2025-2029

The cold chain logistics market for pharmaceuticals industry size is forecast to increase by USD 14.56 billion at a CAGR of 9.9% between 2024 and 2029.

The cold chain logistics market for the pharmaceuticals industry is experiencing significant growth due to the increasing demand for biopharmaceuticals and consumer healthcare products. The consolidation In the global healthcare logistics industry is driving market expansion, with third-party logistics providers increasingly offering specialized services in cold chain logistics. However, functional barriers in cold chain logistics, such as the need for specialized real estate, HVAC systems, and insulated containers, increase operational costs. Advancements in technology are playing a crucial role in mitigating these challenges. For instance, the implementation of blockchain technology in pharmaceutical logistics enhances traceability and security, ensuring the integrity of temperature-sensitive pharmaceuticals like vaccines and insulin during transportation.Furthermore, software solutions utilizing predictive analytics and machine learning enable efficient monitoring of cold chain conditions and proactive intervention in case of deviations. In the realm of freight logistics, air freight remains the preferred mode for transporting temperature-sensitive pharmaceuticals due to its speed and ability to maintain consistent temperatures. However, the high cost of air freight is a significant challenge, necessitating the optimization of packaging and labeling to minimize damage and reduce wastage. In conclusion, the cold chain logistics market for pharmaceuticals is poised for growth, driven by the increasing demand for temperature-sensitive pharmaceuticals and advancements in technology.However, challenges such as high operational costs and the need for specialized infrastructure persist, necessitating continuous innovation and collaboration between stakeholders to ensure the efficient and effective delivery of these vital products.

What will be the Size of the Cold Chain Logistics Market For Pharmaceuticals Industry during the forecast period?

Request Free SampleThe cold chain logistics market for the pharmaceutical industry is a critical sector ensuring the integrity and efficacy of temperature-sensitive pharmaceutical products, including novel drugs, vaccines, biopharmaceuticals, clinical trial materials, and over-the-counter medicines. This market encompasses various stages from transportation in refrigerated or frozen conditions to storage in specialized facilities, labeling, last-mile delivery, and distribution to hospitals & clinics. The market's size is substantial, driven by the increasing demand for temperature-controlled logistics due to the growing number of temperature-sensitive pharmaceutical products. Refrigerated temperature, frozen temperature, and cryogenic temperature logistics are essential for maintaining the efficacy of these products. Key trends include the implementation of advanced technologies like telematics for real-time temperature monitoring and improved supply chain visibility.Sea freight logistics, air freight logistics, and overland logistics are used for transportation, with hubs-to-distributor models optimizing distribution networks. Ambient temperature logistics also play a role In the pharmaceutical supply chain, but the demand for cold chain logistics is expected to continue growing due to the increasing prevalence of temperature-sensitive pharmaceuticals.

How is this Cold Chain Logistics For Pharmaceuticals Industry Industry segmented?

The cold chain logistics for pharmaceuticals industry industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductVaccinesBiopharmaceuticalsClinical trial materialsServiceWarehousing and VASTransportationMode of DeliveryLast-Mile DeliveryHubs-to-DistributorTemperature RangeAmbientRefrigeratedFrozenCryogenicEnd UserHospitals & ClinicsPharmaceuticalBiopharmaceuticalBiotechnology CompaniesOthersGeographyAPACChinaIndiaJapanSouth KoreaNorth AmericaCanadaUSEuropeGermanyUKFranceSouth AmericaBrazilMiddle East and Africa

By Product Insights

The vaccines segment is estimated to witness significant growth during the forecast period.The pharmaceutical industry's reliance on cold chain logistics has grown significantly due to the increasing development and export of temperature-sensitive goods, including novel drugs, vaccines, and biopharmaceuticals. Cold chain logistics ensures the proper transportation, storage, labeling, and last-mile delivery of these goods at specific temperatures - ambient, refrigerated, frozen, or cryogenic. With the rise of advanced technologies like t